Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. monthly Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E15.10 EPS (ttm)5.28 Insider Own0.10% Shs Outstand1.51B Perf Week6.15%
Market Cap120.59B Forward P/E7.69 EPS next Y10.37 Insider Trans0.44% Shs Float1.48B Perf Month-6.01%
Income7.84B PEG3.10 EPS next Q2.22 Inst Own77.80% Short Float5.53% Perf Quarter-11.60%
Sales33.27B P/S3.63 EPS this Y42.30% Inst Trans1.96% Short Ratio6.47 Perf Half Y8.80%
Book/sh-5.51 P/B- EPS next Y8.78% ROA11.90% Target Price93.77 Perf Year-3.86%
Cash/sh26.40 P/C3.02 EPS next 5Y4.88% ROE-95.60% 52W Range62.55 - 97.86 Perf YTD-9.93%
Dividend4.72 P/FCF18.82 EPS past 5Y36.80% ROI21.20% 52W High-18.51% Beta0.81
Dividend %5.92% Quick Ratio3.10 Sales past 5Y10.80% Gross Margin77.10% 52W Low27.50% ATR4.85
Employees30000 Current Ratio3.20 Sales Q/Q4.80% Oper. Margin39.00% RSI (14)52.45 Volatility4.06% 6.89%
OptionableYes Debt/Eq- EPS Q/Q260.00% Profit Margin23.60% Rel Volume0.73 Prev Close78.56
ShortableYes LT Debt/Eq- EarningsMay 01 BMO Payout80.90% Avg Volume12.61M Price79.75
Recom2.30 SMA208.38% SMA50-3.97% SMA2001.53% Volume9,210,829 Change1.51%
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Apr-09-20 11:50AM  Should Value Investors Buy AbbVie (ABBV) Stock? Zacks
11:32AM  Pfizer's Braftovi Combo Gets FDA Nod for Colorectal Cancer Zacks
11:28AM  Form 8.3 - ABBVIE PLC AMENDMENT Business Wire
08:28AM  Form 8.3 - ABBVIE PLC AMENDMENT Business Wire
07:09AM  Form 8.3 - Abbvie Plc Business Wire
06:03AM  Is AbbVie Inc. (NYSE:ABBV) Trading At A 31% Discount? Simply Wall St.
05:41AM  Form 8.3 - AbbVie Inc. Business Wire
Apr-08-20 01:08PM  FORM 8.3 - ABBVIE PLC Business Wire
10:54AM  The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group Zacks
10:49AM  The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products Zacks
10:19AM  Large-Cap Pharma Stocks to Benefit in Post-Pandemic Market Zacks
10:18AM  AbbVie Stock Rises 3% Investing.com
09:34AM  Top Ranked Income Stocks to Buy for April 8th Zacks
08:00AM  Is AbbVie Stock A Buy Amid The Ongoing Coronavirus Pandemic? Investor's Business Daily
05:53AM  Form 8.3 - AbbVie Inc. Business Wire
Apr-07-20 05:45PM  AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Zacks
01:45PM  Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM Zacks
12:48PM  Form 8.3 - ABBVIE PLC AMENDMENT Business Wire
12:00PM  FORM 8.3 - ABBVIE PLC - AMENDMENT Business Wire
09:47AM  Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day Zacks
06:59AM  Signs of Coronavirus Slowdown Pep Up Wall Street: 5 Winners Zacks
06:20AM  Form 8.3 - AbbVie Inc. Business Wire
06:00AM  AbbVie Stock Rises 3% Investing.com
Apr-06-20 04:15PM  A New Technical Strategy for AbbVie TheStreet.com
01:39PM  Another Drug to Fight Coronavirus & 3 Picks Zacks
11:25AM  Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes Zacks
09:00AM  Is AbbVie Stock A Buy As Coronavirus Worries Hammer The Market? Investor's Business Daily
08:00AM  AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes PR Newswire
07:35AM  Form 8.3 - AbbVie Inc. Business Wire
07:25AM  FORM 8.3 - ABBVIE INC Business Wire
Apr-05-20 10:14AM  With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers MarketWatch
Apr-03-20 12:09PM  FORM 8.3 - ABBVIE INC - Amendment Business Wire
11:45AM  Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio Zacks
11:44AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
10:07AM  AbbVie Stock Falls 3% Investing.com
08:10AM  Jim Cramer Gives His Opinion On AbbVie, Domino's Pizza And More Benzinga
07:39AM  Form 8.3 - AbbVie Inc. Business Wire
07:16AM  Form 8.3 - Abbvie Inc Business Wire
06:00AM  Rapid Testing Could Give a Boost to Quidel MoneyShow
Apr-02-20 10:50AM  FORM 8.3 - ABBVIE INC - Amendment Business Wire
08:00AM  AbbVie to Host First-Quarter 2020 Earnings Conference Call PR Newswire
07:48AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
06:41AM  Form 8.3 - AbbVie Inc. Business Wire
Apr-01-20 06:52AM  Form 8.3 - AbbVie Inc. Business Wire
06:43AM  Form 8.3 - ABBVIE INC Business Wire
Mar-31-20 07:24PM  AbbVie Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, Patients and Communities PR Newswire
05:45PM  Buy this High-Yield Large Cap Pharma Stock for Income Amid Coronavirus Zacks
05:45PM  AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks
04:02PM  19 Dividend Aristocrats That Have Gone on Deep Discount Kiplinger
02:18PM  8 Experimental Coronavirus Treatments to Watch Barrons.com
12:32PM  The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie Zacks
11:35AM  Form 8.3 - Abbvie Inc - Amendment Business Wire
11:07AM  Top Ranked Income Stocks to Buy for March 31st Zacks
07:45AM  AbbVie Stock Rises 3% Investing.com
06:00AM  AbbVie- "An Undervalued Superstar" MoneyShow
05:46AM  Form 8.3 - Abbvie Inc Business Wire
Mar-30-20 04:14PM  Best Dividend Stocks for April 2020 Investopedia
12:12PM  Form 8.3 - ABBVIE AMENDMENT Business Wire
05:24AM  Form 8.3 - ABBVIE PLC Business Wire
Mar-29-20 01:16PM  Top Insider Buys Highlight for the Week of March 27 GuruFocus.com
Mar-27-20 12:59PM  The Easy Gains May Be Over for American Airlines Stock InvestorPlace
11:00AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
11:00AM  Big Pharma and Biotech Need to Do More in the Fight Against Covid-19 Barrons.com
09:24AM  Top Ranked Income Stocks to Buy for March 27th Zacks
08:53AM  Will Rescue Deal Impact Last? 4 Coronavirus-Proof Dividend Picks Zacks
06:52AM  FORM 8.3 - ABBVIE PLC Business Wire
05:44AM  AbbVie Stock Falls 4% Investing.com
Mar-26-20 11:51AM  Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus CorpGov.com +8.72%
11:15AM  This portfolio manager draws on 2008 lessons to find stocks that will outlast a pandemic MarketWatch
09:32AM  AbbVie Stock Rises 6% Investing.com
09:14AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
09:05AM  Form 8.3 - Abbvie Inc - Amendment Business Wire
07:57AM  Top Ranked Income Stocks to Buy for March 26th Zacks
06:54AM  FORM 8.3 - ABBVIE PLC Business Wire
Mar-25-20 07:10PM  Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus CorpGov.com
05:45PM  AbbVie (ABBV) Gains But Lags Market: What You Should Know Zacks
12:27PM  Merger Arbitrage Bets Have Steadied as Stocks Bounce Back Barrons.com
11:37AM  FORM 8.3 - ABBVIE PLC Business Wire
11:34AM  Coronavirus Drug Development Race to Boost These 4 Stocks Zacks
09:31AM  AbbVie Stock Rises 3% Investing.com
06:31AM  Form 8.3 - ABBVIE AMENDMENT Business Wire
Mar-24-20 01:34PM  Top Marijuana Stocks That Pay Dividends Investopedia
10:28AM  Top Ranked Income Stocks to Buy for March 24th Zacks
10:20AM  AbbVie's Venclexta Combo Meets Endpoints in Leukemia Study Zacks
09:41AM  FORM 8.3 - ABBVIE PLC - AMENDMENT Business Wire
07:46AM  FORM 8.3 - ABBVIE INC Business Wire
Mar-23-20 12:58PM  Form 8.3 - Abbvie Plc - Amendment Business Wire -6.28%
10:53AM  Is AbbVie a Good Stock to Buy Amid Coronavirus Uncertainty? Zacks
09:12AM  The Zacks Analyst Blog Highlights: Macy's, AbbVie, Pfizer and New Residential Investment Zacks
08:52AM  Form 8.3 - Abbvie Inc - Amendment Business Wire
08:00AM  AbbVie Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA® (venetoclax) in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) PR Newswire
08:00AM  AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes PR Newswire
06:41AM  FORM 8.3 - ABBVIE PLC Business Wire
06:06AM  Big deals in limbo spell arb-ageddon for hedge funds Financial Times
05:37AM  AbbVie Stock Falls 3% Investing.com
01:39AM  AbbVie drops patent rights for Kaletra antiviral treatment Financial Times
Mar-20-20 10:42AM  4 Dividend Stocks to Buy Amid the Coronavirus Rout Zacks
08:09AM  Form 8.3 - Abbvie Inc Business Wire
07:23AM  AbbVie Stock Falls 5% Investing.com
06:32AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
AbbVie Inc., a research-based biopharmaceutical company, develops and markets pharmaceutical products in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a biologic therapy administered as an injection for autoimmune and intestinal diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the treatment of patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; and Janssen Biotech, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Durkin Brian LVP, ControllerMar 30Buy69.0075051,75016,844Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 20Buy67.5080054,00016,094Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 18Buy68.182,200150,00515,294Mar 20 04:56 PM
RAPP EDWARD JDirectorMar 03Buy87.872,875252,6172,875Mar 04 05:14 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerSep 27Sale75.0215,5151,163,8730Oct 01 05:52 PM
Schumacher Laura JVice ChairmanSep 16Buy70.4225,0001,760,523164,838Sep 18 04:25 PM
Donoghoe NicholasSVP, Enterprise InnovationAug 29Buy66.197,525498,05713,090Aug 30 04:08 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsAug 16Buy64.4415,5521,002,16965,304Aug 20 04:16 PM
AUSTIN ROXANNE SDirectorAug 01Buy65.6625,0001,641,400117,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 31Buy66.0230,0001,980,69092,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 30Buy66.3510,000663,50062,114Jul 31 04:46 PM
Gosebruch Henry OEVP, Chief Strategy OfficerJul 29Buy67.2830,0002,018,38575,763Jul 31 04:46 PM
AUSTIN ROXANNE SDirectorJun 26Buy67.5011,500776,25052,114Jun 28 04:47 PM
CHASE WILLIAM JEVP, Finance & AdministrationJun 26Buy67.3030,4002,045,920169,552Jun 28 04:47 PM
RAPP EDWARD JDirectorJun 26Buy67.307,500504,75030,662Jun 28 04:48 PM